Greve Jeffrey W. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 25, 2013
Insider Transaction Report
Form 4
Greve Jeffrey W.
Vice President, Controller
Transactions
- Award
Stock Option to Buy
2013-02-21+8,604→ 8,604 totalExercise: $16.45Exp: 2023-02-21→ Common Stock (8,604 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 21, 2014.